It is a pharma private limited company based in Ambala, Haryana, India, established in 2020.
2020 | Ambala, Haryana, India | ActiveRelward Pharma Private Limited, a active private limited company, was established on 18 November 2020 in Ambala, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299HR2020PTC090989. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
Its leadership includes Krishak Malik (Director), Saurabh Yadav (Director), Sunil Malik (Director). It holds ₹5.55 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Gurbax Gupta Nanhera Road, Vill Nanhera Po Kuldeep Nagar Teh Ambala Cant, Ambala, Haryana, 133004.
U24299HR2020PTC090989
090989
18 November 2020
₹1.50 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Relward Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishak Malik | Director | 18 Nov 2020 | Current |
| Saurabh Yadav | Director | 18 Nov 2020 | Current |
| Sunil Malik | Director | 18 Nov 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Relward Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1517.73% increase. The company also saw a substantial improvement in profitability, with a 218.39% increase in profit. The company's net worth Soared by an impressive increase of 10.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Relward Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,548,453.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2023 | Hdfc Bank Limited | ₹0.70 M | Open |
| 02 Jun 2023 | State Bank Of India | ₹4.00 M | Open |
| 28 Mar 2022 | Hdfc Bank Limited | ₹0.85 M | Open |
Explore comprehensive loan charge details -
Relward Pharma has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Relward Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relward Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Relward Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Relward Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.70 M with Charge ID 100845710 was registered on 21 Nov 2023. was documented.
The activity A charge with State Bank Of India amounted to Rs. 4.00 M with Charge ID 100728466 was registered on 02 Jun 2023. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.85 M with Charge ID 100573457 was registered on 28 Mar 2022. was documented.
The activity Krishak Malik was appointed as a Director was appointed as a Director on 18 Nov 2020 & has been associated with this company since 5 years 1 month . was completed.
The CIN of Relward Pharma Private Limited is U24299HR2020PTC090989.
Relward Pharma Private Limited is headquartered at C/O Gurbax Gupta Nanhera Road, Vill Nanhera Po Kuldeep Nagar Teh Ambala Cant, Ambala, Haryana, 133004.
Relward Pharma Private Limited was incorporated on 18 November 2020.
The current directors of Relward Pharma Private Limited are
The primary industry of Relward Pharma Private Limited is Trade.
Relward Pharma Private Limited is unlisted.
The authorized capital of Relward Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX